These proteins are also involved in DNA replication licensing factors (3–7 subunits in six factors of MCM), the YWHA family (six members) and regulators of cell death besides oxidation reduction, suggesting that MARVELD1 mediates the DDR process and links with cancer therapy [37–40]. This evidence concerns the gene MARVELD1 and cancer.